Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fratta, P.
Right arrow Articles by Askanas, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fratta, P.
Right arrow Articles by Askanas, V.
Related Collections
Right arrow Muscle disease
NEUROLOGY 2004;63:1114-1117
© 2004 American Academy of Neurology
Brief Communications

Mutant ubiquitin UBB+1 is accumulated in sporadic inclusion-body myositis muscle fibers

P. Fratta, MD, W. K. Engel, MD, F. W. Van Leeuwen, PhD, E. M. Hol, PhD, G. Vattemi, MD and V. Askanas, MD PhD

From the USC Neuromuscular Center (Drs. Fratta, Engel, Vattemi, and Askanas), Department of Neurology, University of Southern California Keck School of Medicine, Good Samaritan Hospital, Los Angeles, CA; and Netherlands Institute for Brain Research (Drs. Van Leeuwen and Hol), Research Group Molecular Misreading, Amsterdam, The Netherlands.

Address correspondence and reprint requests to Dr. Valerie Askanas, USC Neuromuscular Center, Good Samaritan Hospital, 637 South Lucas Avenue, Los Angeles, CA 90017-1912; e-mail: askanas{at}hsc.usc.edu

Mutant ubiquitin (UBB+1), a product of "molecular misreading," is toxic to cells because its ubiquitinated form inhibits the proteasome, contributing to accumulation of misfolded proteins and their ensuing toxicity. The authors demonstrate in 10 sporadic inclusion body myositis (s-IBM) muscle biopsies that UBB+1 is accumulated in aggregates containing amyloid-ß and phosphorylated-tau. In s-IBM, UBB+1 may be pathogenic by inhibiting proteasome, thereby promoting accumulation of cytotoxic misfolded amyloid-ß and phosphorylated-tau.

Received February 18, 2004. Accepted in final form May 14, 2004.




This article has been cited by other articles:


Home page
 Cardiovasc ResHome page
N. P. Dantuma and K. Lindsten
Stressing the ubiquitin-proteasome system
Cardiovasc Res, January 15, 2010; 85(2): 263 - 271.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
S. A Greenberg
How citation distortions create unfounded authority: analysis of a citation network
BMJ, July 23, 2009; 339(jul20_3): b2680 - b2680.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
L. G. G. C. Verhoef, C. Heinen, A. Selivanova, E. F. Halff, F. A. Salomons, and N. P. Dantuma
Minimal length requirement for proteasomal degradation of ubiquitin-dependent substrates
FASEB J, January 1, 2009; 23(1): 123 - 133.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
P. van Tijn, F. M. S. de Vrij, K. G. Schuurman, N. P. Dantuma, D. F. Fischer, F. W. van Leeuwen, and E. M. Hol
Dose-dependent inhibition of proteasome activity by a mutant ubiquitin associated with neurodegenerative disease
J. Cell Sci., May 1, 2007; 120(9): 1615 - 1623.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
C. E. Finch
A perspective on sporadic inclusion-body myositis: The role of aging and inflammatory processes
Neurology, January 24, 2006; 66(1_suppl_1): S1 - S6.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
V. Askanas and W. K. Engel
Inclusion-body myositis: A myodegenerative conformational disorder associated with A{beta}, protein misfolding, and proteasome inhibition
Neurology, January 24, 2006; 66(1_suppl_1): S39 - S48.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
F. W. van Leeuwen, P. van Tijn, M.A.F. Sonnemans, B. Hobo, D. M.A. Mann, C. Van Broeckhoven, S. Kumar-Singh, P. Cras, G. Leuba, A. Savioz, et al.
Frameshift proteins in autosomal dominant forms of Alzheimer disease and other tauopathies
Neurology, January 24, 2006; 66(1_suppl_1): S86 - S92.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
P. Fratta, W. K. Engel, J. McFerrin, K. J.A. Davies, S. W. Lin, and V. Askanas
Proteasome Inhibition and Aggresome Formation in Sporadic Inclusion-Body Myositis and in Amyloid-{beta} Precursor Protein-Overexpressing Cultured Human Muscle Fibers
Am. J. Pathol., August 1, 2005; 167(2): 517 - 526.
[Abstract] [Full Text] [PDF]